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Abstract
Background: Obesity and overweight are consistently associated with metabolic disorders including hyperglycemia
and hyperlipidemia. Herbal medicines have been currently suggested as an alternative source of potentially useful
antihyperglycemic, antihyperlipidemic, antioxidant activities. The objective of this study was to assess the in vitro
inhibitory effects of eleven herbal medicines on carbohydrate and lipid digestive enzymes and the key steps of
lipid digestion including the inhibition of micelle formation and the ability to bind bile acid. In addition, antioxidant
activity of herbal medicines was also investigated.
Methods: α-Glucosidase, pancreatic α-amylase, pancreatic lipase, and pancreatic cholesterol esterase inhibitory
activities of aqueous extract of herbal medicines were measured using the enzymatic colorimetric assay. The
formation of cholesterol micelles was determined using the cholesterol assay kit. The bile acid binding was
measured using the colorimetric assay. Antioxidant activities were assessed by using four methods including
Trolox equivalent antioxidant capacity (TEAC), oxygen radical absorbance capacity ORAC), superoxide radical
scavenging activity (SRSA), and hydroxyl radical scavenging activity (HRSA).
Results: The extracts (1 mg/mL) markedly inhibited intestinal maltase (5.16 − 44.33 %), sucrase (1.25–45.86 %),
pancreatic α-amylase (1.75–12.53 %), pancreatic lipase (21.42–85.93 %), and pancreatic cholesterol esterase
(2.92–53.35 %). The results showed that all extracts exhibited the inhibitory activity against pancreatic lipase
with the IC50 values ranging from 0.015 to 4.259 mg/mL. In addition, the incorporation of cholesterol into
micelles was inhibited by the extracts (6.64–33.74 %). The extracts also bound glycodeoxycholic acid (9.9–15.08 %),
taurodeoxycholic acid (12.55–18.18 %), and taurocholic acid (11.91 − 18.4 %). Furthermore, the extracts possessed
various antioxidant activities including the TEAC values (0.50 − 4.70 μmol trolox/mg dried extract), the ORAC values
(9.14–44.41 μmol trolox/mg dried extract), the SRSA (0.31 − 18.82 mg trolox/mg dried extract), and the HRSA
(0.05–2.29 mg trolox/mg dried extract). The findings indicated that Syzygium aromaticum, Phyllanthus amarus,
Thunbergia laurifolia were the effective promising antihyperglycemic and antihyperlipidemic agents. Statistical
analysis demonstrated strong positive significant correlations between the contents of phenolic compounds and
% inhibition of pancreatic lipase (r = 0.885, p < 0.001), % inhibition of pancreatic cholesterol esterase (r = 0.761,
p < 0.001), and the TEAC value (r = 0.840, p < 0.001). Furthermore, there was a strongly positive correlation between
the TEAC value and % inhibition of pancreatic cholesterol esterase (r = 0.851, p < 0.001) and % inhibition of
pancreatic lipase (r = 0.755, p < 0.001).
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Conclusions: Three herbal medicines including Syzygium aromaticum, Thunbergia laurifolia, and Phyllanthus amarus
markedly inhibited the intestinal α-glucosidase, pancreatic α-amylase, pancreatic lipase, and pancreatic cholesterol
esterase. They also reduced formation of cholesterol micelle and bound bile acid. The findings indicate that these
herbal medicines might be a promising agent for antihyperglycemic, antihyperlipidemic, and antioxidant activities.
Keywords: Herbal medicines, Antihyperglycemia, Antihyperlipidemia, Antioxidant
Background
The prevalence of obesity and overweight has dramat-
ically increased worldwide due to a modern lifestyle
and an increase of consumption of high-fat and high-
carbohydrate diets [1]. Obesity and overweight are con-
sistently associated with the elevation of blood glucose
and lipid levels. Hyperglycemia and hyperlipidemia are
major risk factors for developing chronic diseases such
as diabetes mellitus and cardiovascular diseases [1].
One of the interesting strategies for the prevention of
obesity is to reduce or slow dietary carbohydrate and
fat digestion and absorption in the small intestine [2,
3]. The results from this action cause attenuated rises
in postprandial hyperglycemia, hypertriacylglycerole-
mia and hypercholesterolemia, consequently, reduced
risks of the progression of cardiovascular diseases and
diabetes and its complications [4, 5]. Additionally, con-
sumption of carbohydrate- and fat-enriched foods
results in a significant increase in postprandial glucose
and oxidative stress by the formation of reactive oxy-
gen species through several biochemical pathways
[6]. Current evidence supports that the well-known
α-glucosidase inhibitors (acarbose and voglibose) and
pancreatic lipase inhibitor (orlistat) are clinically used
for treatment of hyperglycemia and hyperlipidemia
[7, 8]. In overweight and obese people, the suppression
of postprandial glucose and lipid levels may reduce the
incidence of developing diabetes and its complications
[9]. However, they have been reported that use of these
inhibitors is associated with unpleasant gastrointestinal
side effects such as abdominal pain, flatulence, meteorism,
and diarrhea [10, 11].
Nowadays, numerous herbal medicines have been
reported as good sources of unique phytochemical
compounds such as polyphenols and flavonoids. The
scientists have investigated potential herbal medicines
for the development of newer therapeutics for biologic-
ally active antioxidants, antihyperlipidemic and antihy-
perglycemic agents from natural resources, especially
the reduction of carbohydrate and fat digestion and
absorption [12, 13]. As described in Table 1, herbal
medicines have been commonly used for the treatment
of various diseases in the Ayurvedic system of Thai
traditional medicine. Previous reports have shown the
methylglyoxal-trapping abilities of herbal medicines
and their inhibitory activities on the formation of pro-
tein glycation [14, 15]. Nevertheless, studies addressing
the inhibition of these herbal medicines on the key
enzymes and steps of carbohydrate and lipid digestions
remain unknown. Therefore, the present investigation
was to evaluate the effects of eleven herbal medicines
on the intestinal α-glucosidases and pancreatic α-amylase.
Moreover, the study was also investigated the inhibition
of pancreatic lipase and pancreatic cholesterol esterase
activities as well as inhibiting formation of cholesterol
micellization, and bile acid binding. Finally, eleven
herbal medicines were elucidated their antioxidant ac-
tivities including Trolox equivalent antioxidant capacity
(TEAC), oxygen radical absorbance capacity (ORAC),
hydroxyl radical scavenging activity (HRSA), and super-
oxide radical scavenging activity (SRSA).
Methods
Chemicals
Gallic acid, rat intestinal acetone powder, porcine pan-
creatic α-amylase, 4-methylumbelliferone, glucose oxidase
kits and 3,5-dinitrosalicylic acid p-nitrophenylbutylrate (p-
NPB), oleic acid, phosphatidylcholine, glycodeoxycholic
acid, taurodeoxycholic acid, taurocholic acid, porcine
cholesterol esterase, porcine pancreatic lipase were pur-
chased from Sigma-Aldrich Co. (St. Louis, MO, USA).
Cholesterol test kits were purchased from HUMAN
GmbH Co. (Wiesbaden, Germany). Total bile acid kit
was purchased from Bio-Quant Co. (San Diego, CA,
USA). All other chemical reagents used in this study
were of analytical grade.
Plant materials
The plants were purchased from a specific herbal drug-
store, Bangkok, Thailand. The plant authentication was
performed according to our previous report [15]. The
extraction of herbal medicines was done according to a
previous report [15]. Briefly, the plants (20 g) were
boiled in distilled water (800 mL) for 3 h at 95 °C
before filtered through Whatman No. 1 filter paper.
Thereafter, the extraction was lyophilized with a freeze
drier. The lyophilized powder was stored at 4 °C in a
dark bottle until analysis. The powder of extracts (final
concentration: 1 mg/mL) was resuspended in distilled
water before experiments.
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Intestinal α-glucosidase inhibitory activity
The intestinal α-glucosidase inhibitory activity was de-
termined according to a previous method [16]. Briefly,
100 mg of rat intestinal acetone powder was homoge-
nized in 3 mL of 0.9 % NaCl solution. The solution was
centrifuged at 12,000 g for 30 min and then subjected to
assay. The crude enzyme solution was incubated with
25 mM maltose or 160 mM sucrose together with vari-
ous extracts in 0.1 M phosphate buffer (PBS), pH 6.9.
The reaction was incubated at 37 °C for 30 min (maltase
assay) or 60 min (sucrase assay). Thereafter, the mixtures
were suspended in boiling water for 10 min to stop the
reaction. The concentrations of glucose released from
the reaction mixtures were determined by glucose
oxidase method with the absorbance at a wavelength
of 450 nm. Intestinal maltase and sucrase inhibitory
activity was expressed as the percentage inhibition
using the following formula:
% Inhibition ¼ AbsControl−AbsSample
AbsControl
 100
Acarbose was used as positive control in this study.
Pancreatic α-amylase inhibitory activity
The pancreatic α-amylase inhibition assay was done
according to a previous method [16]. The various con-
centrations of the extracts were incubated with solution
containing porcine pancreatic α-amylase (3 units/mL),
starch (1 g/L), and 0.1 M PBS, pH 6.9, for 10 min, the
reaction was then stopped by 1 % dinitrosalicylic (DNS)
reagent (3,5-dinitrosalicylic acid, 0.2 % phenol, 0.05 %
Na2SO3 and 1 % NaOH in aqueous solution). After
heating at 100 °C for 10 min, 40 % potassium sodium
tartarate solution was added to the mixtures to stabilize
the color. After cooling to room temperature in a cold
water bath, the absorbance was measured at 540 nm
using a microplate reader.
% Inhibition ¼ AbsControl−AbsSample
AbsControl
 100
Where AbsControl was the absorbance without sample,
Abssample was the absorbance of sample extract. Acarbose
was used as positive control in this study.
Pancreatic lipase inhibition
Pancreatic lipase activity was done according to a previous
method [17]. The sample solution was incubated with the
pancreatic lipase solution (12.5 U/mL) and 0.05 mM
oleate ester of fluorescent 4-methylumbelliferone (4MUO)
solution in 0.1 M PBS, pH 6.9. After incubation at 37 °C
for 20 min, the reaction was terminated by 0.1 M sodium
citrate (pH 4.2). The amount of 4-MUO released by lipase
was determined using a fluorescence spectrophotometer
at an excitation wavelength of 320 nm and an emission
wavelength of 450 nm. Orlistat was used as a positive
control in this study.
Table 1 The list of plants was used of this study
Plant samples
Scientific name Family Used part Bioactive compounds Medicinal properties
Rhinacanthus nasutus Acanthaceae Leaves Rhinacanthin [34] Antidiabetes [35], antimicrobial [36],
antiproliferative [34]
Cissus quadrangularis Vitaceae Aerial parts Flavonoids, triterpenoids, tannins [37] Antidiabetes [37], hepatoprotective [38],
antiobesity [39], bone health [40]
Syzygium aromaticum Myrtaceae Buds Eugenol (essential oil), flavonoids, aromatic
hydroxy acids, tannins [41], triterpenoids [25]
Antioxidant [41], antiulcer [42],
immunomodulatory [43],
anticancer [44], antidiabetes [25]
Acanthus ebracteatus Acanthaceae Leaves Megastigmane, benzoxazinoids [45] Antimicrobial [45], antitumor [46]
Thunbergia laurifolia Acanthaceae Leaves Rosmarinic acid [47], polyphenols,
carotenoids, sterols [48]
Antiinflammatory [47], antimutagenic [49],
antidiabetes [30], hepatoprotective [50],
Phyllanthus amarus Euphorbiaceae Aerial parts Triterpenoids, lignans [51] Immunosuppressive [52], antimicrobial,
antiinflammatory [53], antioxidant [54]
Cassia alata Leguminosae Leaves Antraquinones, flavonoids [55] Antioxidant, antiinflammatory [56],
antimicrobial [55]
Pluchea indica Asteraceae Aerial parts Eudesmane, terpenoids, thiophene,
lignins, flavonoids [57]
Antiinflammatory [57], antituberculosis [58],
antiulcer [59]
Cryptolepis buchanani Asclepiadaceae Aerial parts Nicotinoyl alkaloid, pyridine alkaloid [60] Antiinflammatory [60]
Derris scandens Fabaceae Aerial parts Isoflavone, isoscandinone, scandenins [61, 62] Antiinflammatory [61], antidiabetes [62]
Schefflera leucantha Araliaceae Leaves Steroids, terpenoids, flavonoids [63] Antioxidant, antityrosinase, antimicrobial [63]
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Pancreatic cholesterol esterase inhibition
The pancreatic cholesterol esterase inhibition was per-
formed according a previously described method [17].
The extract was incubated with the mixtures containing
5.16 mM taurocholic acid, 0.2 mM p-NPB in 100 mM
sodium phosphate buffer, 100 mM NaCl, pH 7.0. After
incubation with porcine pancreatic cholesterol esterase
(1 μg/mL) for 5 min at room temperature, the mixtures
were measured the absorbance at the wavelength of
405 nm. Simvastatin was used as a positive control for
this study.
Cholesterol micellization
Artificial micelles were prepared according to a previously
described method [17]. In brief, the mixtures (2 mM
cholesterol, 1 mM oleic acid, and 2.4 mM phosphatidyl-
choline) were dissolved in methanol and dried under
nitrogen before adding 15 mM PBS containing 6.6 mM
taurocholate salt, at pH 7.4. The suspension was soni-
cated twice for 30 min using a sonicator. The micelle
solution was incubated overnight at 37 °C. The extract
or equivalent PBS as control were added to the mixed
micelle solution and incubated for a further 2 h at 37 °C.
The solution was then centrifuged at 16,000 rpm for
20 min. The supernatant was collected for the deter-
mination of cholesterol by using total cholesterol test
kits. Gallic acid was used as a positive control.
Bile acid binding
The bile acid binding assay was done according to a
previous method [17]. Taurocholic acid, glycodeoxy-
cholic acid and taurodeoxycholic acid were used as bile
acid in this experiment. Briefly, the extract (1 mg/mL)
was incubated with each bile acid (2 mM) containing in
0.1 M PBS, pH 7 at 37 °C for 90 min. The mixtures
were filtered through 0.2 μm filter and the bile acid
concentration was determined using a bile-acid analysis
kit. Cholestyramine was used as a positive control in
this study.
Trolox equivalent antioxidant capacity (TEAC) assay
The TEAC assay was performed according to a previous
publication [14]. The absorbance was measured at 595
after incubation using a spectrophotometer. The TEAC
value was calculated from a standard curve using a
Trolox. The TEAC value was expressed as micromole
of Trolox equivalents per milligram of extract.
Oxygen radical absorbance capacity (ORAC) assay
The ORAC assay was determined according to a previ-
ously described method by using 2,2’-azo-bis (2-amidino-
propane) dihydrochloride (APPH), a free radical generator
solution [14]. The fluorescence intensity at an excitation
wavelength 485 nm and emission wavelength 535 nm was
recorded every 2 min for 60 min. A standard curve was
generated with a Trolox concentration range from 0 to
48 μM. The ORAC value was calculated as the area under
the curve (AUC) and expressed as micromole of Trolox
equivalents per milligram of extract.
Hydroxyl radical scavenging activity (HRSA)
The HRSA was measured according to a previously de-
scribed method by using the mixture of hydroxyl radical
solution [14]. The absorbance was measured at 532 nm.
The HRSA value was calculated from a standard curve
using a Trolox. The HRSA value was expressed as milli-
gram of Trolox equivalents per milligram of extract.
Superoxide radical scavenging activity (SRSA)
The SRSA was measured according to a previously de-
scribed publication by using the mixture of superoxide
radical solution [14]. After incubation for 40 min at 37 °C,
the absorbance was determined at 560 nm. The SRSA
value was calculated from a standard curve using a Trolox.
The SRSA value was expressed as milligram of Trolox
equivalents per milligram of extract.
Statistical analysis
Data were expressed as mean ± standard error of the mean
of three replicate determinations. Pearson’s correlation
analysis was used to determine the correlation between
total phenolic content (TPC) and antioxidant activity, the
percentage of inhibition of pancreatic lipase, and pancre-
atic cholesterol esterase (SPSS Statistics 17.0, SPSS Inc.,
Chicago, IL, USA). A value of P < 0.001 was considered
to be statistically significant.
Results
The results in Table 2 demonstrate the percentage in-
hibition of herbal medicines against the intestinal α-
glucosidases (maltase and sucrase) and pancreatic α-
amylase. At concentration of 1 mg/mL, herbal medicines
markedly inhibited intestinal maltase, ranging from
5.16–44.33 %. Among eleven herbal extracts, Syzygium
aromaticum and Schefflera leucantha were the highest
and lowest effective intestinal maltase inhibitor, re-
spectively. They slightly inhibited the intestinal sucrase
with the percentage inhibition of 1.25–45.86 %. It was
found that Phyllanthus amarus was the most effective
inhibitor, whereas Cissus quadrangularis had the lowest
potent intestinal sucrase inhibitor among those of ex-
tracts. It was noted that herbal medicines showed weak
inhibition against pancreatic α-amylase (1.75–12.53 %).
Furthermore, acarbose (0.005 mg/mL) markedly inhib-
ited intestinal maltase and sucrase with 64.87 ± 0.32 %
and 11.42 ± 2.49 %, respectively. At the concentration
of 0.16 mg/mL, acarbose had pancreatic α-amylase in-
hibitory activity with 60.22 ± 2.90 %.
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The results of pancreatic lipase and cholesterol ester-
ase inhibition by various herbal medicines (1 mg/mL)
are summarized in Table 2. A variety of the tested plant
extracts showed a strong inhibitory potential against
pancreatic lipase with ranging from 21.42 to 85.93 %.
The extracts were further investigated for their pancre-
atic lipase inhibitory effects at different concentrations.
The results showed that all extracts markedly inhibited
pancreatic lipase activity in a concentration-dependent
manner. As shown in Fig. 1, Syzygium aromaticum was
the most effective pancreatic lipase inhibitor with IC50
values of 0.015 ± 0.002 mg/mL, whereas Cissus quadran-
gularis was the lowest potent inhibitor among those of
the extracts (IC50 = 4.259 ± 0.131 mg/mL). However, all
extracts were less potent than that of orlistat on inhib-
ition of pancreatic lipase (IC50 = 0.058 ± 0.005 mg/mL).
Table 2 % Inhibition of herbal medicines (1 mg/mL) against pancreatic α-amylase, the intestinal α-glucosidase (maltase and sucrase),
pancreatic lipase, and pancreatic cholesterol esterase
Plant samples % Inhibition
α-Pancreatic amylase Maltase Sucrase Pancreatic lipase Pancreatic cholesterol esterase
Rhinacanthus nasutus N.I. 2.72 ± 0.93 6.10 ± 1.43 55.82 ± 4.34 15.06 ± 0.56
Cissus quadrangularis 2.98 ± 0.03 7.50 ± 1.12 3.99 ± 1.44 21.42 ± 4.36 12.79 ± 3.32
Syzygium aromaticum N.I 44.33 ± 2.96 45.08 ± 2.22 85.93 ± 0.53 53.55 ± 1.07
Acanthus ebracteatus N.I 11.72 ± 4.91 2.69 ± 0.41 29.64 ± 4.19 2.92 ± 1.05
Thunbergia laurifolia 11.40 ± 2.58 10.10 ± 0.49 16.62 ± 3.11 54.25 ± 3.00 25.39 ± 2.42
Phyllanthus amarus 12.53 ± 3.00 38.25 ± 0.60 48.49 ± 1.85 65.30 ± 0.47 20.04 ± 0.41
Cassia alata 6.80 ± 2.63 5.66 ± 0.58 1.25 ± 0.49 59.24 ± 1.37 18.14 ± 1.55
Pluchea indica 12.04 ± 1.80 30.31 ± 2.15 1.84 ± 0.20 50.94 ± 0.12 12.76 ± 1.46
Cryptolepis buchanani N.I. 5.16 ± 0.90 4.30 ± 1.02 38.79 ± 1.85 24.72 ± 1.91
Derris scandens 1.75 ± 0.86 8.09 ± 0.87 4.30 ± 1.02 51.48 ± 0.26 10.30 ± 0.73
Schefflera leucantha N.I. N.I. 5.25 ± 2.01 38.51 ± 1.50 30.90 ± 2.45
Acarbosea,b 60.22 ± 2.90 64.87 ± 0.32 11.42 ± 2.49 - -
Orlistatc - - - 76.55 ± 2.72 -
Simvastatind - - - - 51.01 ± 0.79
Results are represented as mean ± SEM (n = 3). N.I. = No inhibition. aAcarbose at concentration 0.16 mg/mL for pancreatic α-amylase inhibition and bacarbose at
concentration 0.005 mg/mL for maltase and sucrase inhibition. cOrlistst at concentration 0.063 mg/mL. dSimvastatin at concentration 0.13 mg/mL
Fig. 1 The IC50 values of herbal medicines against pancreatic lipase. The results are represented as mean ± SEM (n = 3)
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At concentration of 1 mg/mL, Syzygium aromaticum
markedly inhibited pancreatic cholesterol esterase activity
with 53.35 ± 1.07 %, whereas other herbal medicines atten-
uated this enzyme activity with the range of 2.92–30.9 %.
In addition, simvastatin had the percentage inhibition of
51.01 ± 0.79 % at the concentration of 0.13 mg/mL.
The results in Table 3 describe the percentage inhibition
of herbal medicines (1 mg/mL) on cholesterol micelliza-
tion. Syzygium aromaticum, Phyllanthus amarus, Rhina-
canthus nasutus, and Thunbergia laurifolia slightly
reduced the formation of cholesterol micellization with
values of 2.29–33.74 %, whereas other herbal medicines
had no inhibitory activity. Gallic acid (0.06 mg/mL) mark-
edly inhibited the formation of cholesterol micelles about
32.48 ± 3.33 %. The percentage of bile acid binding by
herbal medicines (1 mg/mL) is shown in Table 3. The
results showed that Phyllanthus amarus demonstrated the
highest binding of glycodeoxycholic acid and taurocholic
acid with a degree of 15.08 % and 18.40 %, respectively.
The highest binding of taurodeoxycholic acid was ob-
served with Syzygium aromaticum (18.18 %). Additionally,
cholestyramine (1 mg/mL) bound 55.07 ± 2.85 %, 36.86 ±
2.27 %, and 61.20 ± 1.44 % of glycodeoxycholic acid,
taurocholic acid, and taurodeoxycholic acid, respectively.
Antioxidant activities of eleven herbal medicines are
presented in Table 4. The results demonstrated that the
extracts had various antioxidant activity including
TEAC, ORAC, SRSA, and HRSA with the range of
0.50–4.70 μmol trolox/mg dried extract, 9.14–44.41 μmol
trolox/mg dried extract, 0.31–18.82 mg trolox/mg dried
extract, and 0.05–2.29 mg trolox/mg dried extract, re-
spectively. Comparing with a previous study [14], it was
found that the highest TEAC, ORAC, and SRSA were
elicited by Syzygium aromaticum. It was observed that
Cissus quadrangularis had the highest SRSA in compari-
son with other herbal medicines.
The total phenolic content (TPC) of extracts was pre-
viously reported by our experiments [15] that have been
used for the calculation of Pearson’s correlation coeffi-
cients in the present study. The Pearson’s correlation coef-
ficients between the variables are presented in Table 5.
There were strong positive significant correlation between
the contents of phenolic compounds and % inhibition of
pancreatic lipase (r = 0.885, p < 0.001), % inhibition of pan-
creatic cholesterol esterase (r = 0.761, p < 0.001), and the
TEAC value (r = 0.840, p < 0.001). Furthermore, a strongly
positive correlation was also found between the TEAC
value and % inhibition of pancreatic cholesterol esterase
(r = 0.851, p < 0.001) and % inhibition of pancreatic lipase
(r = 0.755, p < 0.001). In contrast, the negative correlation
was observed between the HRSA and the SRSA value.
Discussion
Herbal medicines remain one of the most alternative ap-
proaches for the prevention and management of chronic
degenerative diseases such as type 2 diabetes and cardio-
vascular diseases [12, 13]. Consumption of carbohydrate
and fat enriched foods causes a rapid rise in the blood
glucose and lipid profiles. In this regards, inhibition of
pancreatic α-amylase and α-glucosidase impedes the
postprandial glucose excursion to enable overall smooth
glucose profile. Recent evidence also supports that
aggressive delaying dietary fat digestion and absorption
is a new strategy for prevention of hyperlipidemia [18].
Inhibition of pancreatic lipase and pancreatic cholesterol
esterase results in delaying the process of hydrolyzing
dietary triglyceride and cholesterol esters, respectively
[19, 20]. In meantime, binding bile acids by forming
Table 3 The effect of herbal medicines (1 mg/mL) on inhibition of cholesterol micellization and bile acid binding
Plant samples % Bile acid binding
% Cholesterol micellization inhibition Glycodeoxycholic acid Taurocholic acid Taurodeoxycholic acid
Rhinacanthus nasutus 2.29 ± 0.77 N.I. N.I. N.I.
Cissus quadrangularis N.I. N.I. N.I. N.I.
Syzygium aromaticum 18.43 ± 0.179 13.47 ± 1.41 18.40 ± 2.04 18.18 ± 1.74
Acanthus ebracteatus N.I. N.I. N.I. N.I.
Thunbergia laurifolia 6.64 ± 0.67 9.90 ± 1.01 11.91 ± 1.36 12.55 ± 2.34
Phyllanthus amarus 33.74 ± 0.23 15.08 ± 1.44 16.77 ± 1.74 13.36 ± 4.51
Cassia alata N.I. N.I. N.I. N.I.
Pluchea indica N.I. N.I. N.I. N.I.
Cryptolepis buchanani N.I. N.I. N.I. N.I.
Derris scandens N.I. 2.05 ± 0.27 4.19 ± 2.61 5.70 ± 0.39
Schefflera leucantha N.I. N.I. 1.76 ± 0.75 3.17 ± 1.21
Gallic acid (0.06 mg/mL) 32.48 ± 3.33 - - -
Cholestyramine (1 mg/mL) - 55.07 ± 2.58 36.86 ± 2.27 61.20 ± 1.44
Results are represented as mean ± SEM (n = 3). N.I. = No inhibition
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insoluble complexes and increasing their fecal excretion
as well as the reduction of micelle formation have been
referred to as possible mechanisms for lowering blood
cholesterol level [21]. Additionally, postprandial oxida-
tive stress has been linked with consumption of a meal
rich in lipids and/or carbohydrates [22]. The present
findings are important, particularly in view of antihyper-
glycemic and antihyperlipidemic mechanisms of eleven
herbal medicines including the intestinal α-glucosidase,
pancreatic α-amylase, pancreatic lipase and pancreatic
cholesterol esterase inhibitory activities as well as bile
acid binding and the inhibition of cholesterol micelliza-
tion. Furthermore, the medicinal properties of the plants
have been explored for their potential antioxidant.
Among the plant extracts examined, three herbal medi-
cines exhibit a high potential for antihyperglycemic and
antihyperlipidemic activity including Syzygium aromati-
cum, Thunbergia laurifolia and Phyllanthus amarus.
There are several reports demonstrating antihypergly-
cemic and antihyperlipidemic activity of three herbal
medicines. For example, clove (Syzygium aromaticum)
bud powder reduced blood glucose level in a high fat-
induced diabetic rat [23]. A previous study revealed that
eugeniin, the phytochemical compounds isolated from
aqueous methanol extraction was attributed with the
inhibition of rat intestinal maltase [24]. The present in-
vestigation evaluated the inhibitory activity of pancreatic
α-amylase and α-glucosidase by using water-solvent
extraction. The extraction method differs from previous
studies which may result in various biological activities.
Syzygium spp-derived triterpenes oleanolic acid (OA)
and maslinic acid (MA) ameliorated postprandial hyper-
glycemia in diabetic rats through the inhibition of intes-
tinal α-glucosidase and α-amylase [25]. OA have been
reported to inhibit α-glucosidase as uncompetitive inhib-
ition. The inhibitory activity of OA may be due to the tri-
terpenoid structure [26]. The aqueous extract of Syzygium
aromaticum also inhibited fructose-induced protein glyca-
tion and oxidation [14]. Furthermore, the ethanolic extract
of Syzygium aromaticum markedly reduced serum trigly-
ceride and cholesterol in high-fat diet-induced obese mice
through downregulation of adipogenic and lipogenic gene
expression [27]. However, other mechanisms of antihyper-
lipidemic activity of Syzygium aromaticum have not been
described. The methanolic extract of Phyllanthus amarus
was reported to have hypoglycemic effect on alloxan-
induced diabetic rats [28]. In addition, significant alter-
ations in lipid profiles were attenuated in diabetic rats
treated with Phyllanthus amarus aqueous extract [29].
Moreover, the 15-day-treatment of Thunbergia laurifolia
decreased plasma glucose concentration in diabetic rats
Table 4 Antioxidant activity of herbal medicines including TEAC, ORAC, HRSA and SRSA
Plant samples Antioxidant activity
TEAC ORAC SRSA HRSA
Rhinacanthus nasutus 0.92 ± 0.01 18.31 ± 0.07 5.31 ± 0.45 1.86 ± 0.02
Cissus quadrangularis 0.52 ± 0.01 9.14 ± 0.05 0.31 ± 0.03 2.29 ± 0.05
Syzygium aromaticum 4.70 ± 0.03a 31.21 ± 0.21a 18.82 ± 0.50a 0.15 ± 0.04a
Acanthus ebracteatus 0.50 ± 0.01 10.77 ± 0.23 9.47 ± 0.39 0.38 ± 0.01
Thunbergia laurifolia 1.07 ± 0.01 44.41 ± 0.53 14.39 ± 0.24 1.48 ± 0.08
Phyllanthus amarus 1.40 ± 0.01 19.70 ± 0.17 15.77 ± 0.45 0.06 ± 0.02
Cassia alata 0.69 ± 0.01 14.63 ± 0.13 4.89 ± 0.31 1.15 ± 0.04
Pluchea indica 1.61 ± 0.01 28.06 ± 0.19 19.38 ± 0.50 0.05 ± 0.01
Cryptolepis buchanani 1.01 ± 0.01 21.22 ± 0.05 10.30 ± 0.18 1.14 ± 0.01
Derris scandens 1.38 ± 0.01 18.21 ± 0.23 7.32 ± 0.24 1.46 ± 0.01
Schefflera leucantha 0.86 ± 0.02 19.61 ± 0.44 7.80 ± 0.42 0.59 ± 0.02
Data are expressed as mean ± S.E.M, n = 3. TEAC was expressed as micromole trolox/ mg dried extract. ORAC was expressed as micromole trolox/ mg dried
extract. Hydroxyl radical scavenging activity (HRSA) was expressed as milligram trolox/mg dried extract. Superoxide radical scavenging activity (SRSA) was
expressed as milligram trolox/mg dried extract. aantioxidant activity of Syzygium aromaticum was previously reported by our publication [62]
Table 5 Pearson’s correlation analyses of total phenolic content
(TPC), % inhibition of pancreatic lipase (PL) (1 mg/mL), %
inhibition of pancreatic cholesterol esterase (Chol) (1 mg/mL),
ORAC, TEAC, SRSA, and HRSA
TPC PL Chol ORAC TEAC SRSA HRSA
TPC - 0.885* 0.761* 0.386 0.840* 0.594 -0.441
PL - - 0.643 0.547 0.755* 0.648 -0.454
Chol - - - 0.490 0.851* 0.389 -0.197
ORAC - - - - 0.459 0.698 -0.203
TEAC - - - - - 0.642 -0.457
SRSA - - - - - - -0.785*
HRSA - - - - - - -
*Correlation is significant at P < 0.001
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[30]. Taken together, the present findings might describe
antihyperglycemic and antihyperlipidemic mechanisms of
three herbal medicines in diabetic rats.
Several reports support that total phenolic compounds
in the herbal medicines have the ability to inhibit pan-
creatic α-amylase, α-glucosidase, pancreatic lipase activity
and pancreatic cholesterol esterase [12, 31] whereas they
reduce the formation of cholesterol micelles and bile acid
binding [31, 32]. Other studies published earlier also
showed positive correlation between phenolic compounds
and the antioxidant activity of plant extracts and pancre-
atic lipase inhibitory activity [33]. The present results
demonstrate a significant positive correlation between
phenolic contents and pancreatic lipase inhibition activity,
pancreatic cholesterol esterase, and antioxidant activity
(TEAC) which provide strong support that phenolic
compounds are key agents for pancreatic lipase and
pancreatic cholesterol esterase inhibition as well as
antioxidant activity.
Conclusions
Eleven herbal medicines markedly demonstrated antioxi-
dant, antihyperglycemic, and antihyperlipidemic activities,
in particular, Syzygium aromaticum, Thunbergia laurifolia
and Phyllanthus amarus. Interestingly, the phenolic
compounds in the promising herbal medicines exhibited
strong correlation to the inhibitory activity against pancre-
atic lipase, pancreatic cholesterol esterase, and the TEAC
values. These results indicate that these herbal medicines
could be a natural source for antioxidant, antihyperglyce-
mic, and antihyperlipidemic agents.
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